Works by Højgaard, Martin

Results: 9
    1
    2
    3

    Actionable alterations in glioblastoma: Insights from the implementation of genomic profiling as the standard of care from 2016 to 2023.

    Published in:
    Neuro-Oncology Practice, 2025, v. 12, n. 1, p. 34, doi. 10.1093/nop/npae082
    By:
    • Fougner, Vincent;
    • Urup, Thomas;
    • Poulsen, Hans Skovgaard;
    • Grunnet, Kirsten;
    • Westmose, Christina Yde;
    • Melchior, Linea Cecilie;
    • Larsen, Karen Bonde;
    • Højgaard, Martin;
    • Spanggaard, Iben;
    • Belcaid, Laila;
    • Rohrberg, Kristoffer Staal;
    • Lassen, Ulrik;
    • Hasselbalch, Benedikte;
    • Nørøxe, Dorte Schou
    Publication type:
    Article
    4

    Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact.

    Published in:
    Acta Oncologica, 2022, v. 61, n. 12, p. 1499, doi. 10.1080/0284186X.2022.2156809
    By:
    • Jacobsen, Ida Christine;
    • Spanggaard, Iben;
    • Højgaard, Martin;
    • Belcaid, Laïla;
    • Qvortrup, Camilla;
    • Yde, Christina Westmose;
    • Schmidt, Ane Yde;
    • Nielsen, Finn Cilius;
    • Willemoe, Gro Linno;
    • Dam, Mikkel Seidelin;
    • Lassen, Ulrik;
    • Staal Rohrberg, Kristoffer
    Publication type:
    Article
    5

    Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study).

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1439, doi. 10.1093/jnci/djae098
    By:
    • Fontana, Elisa;
    • Rosen, Ezra;
    • Lee, Elizabeth K;
    • Højgaard, Martin;
    • Mettu, Niharika B;
    • Lheureux, Stephanie;
    • Carneiro, Benedito A;
    • Cote, Gregory M;
    • Carter, Louise;
    • Plummer, Ruth;
    • Mahalingam, Devalingam;
    • Fretland, Adrian J;
    • Schonhoft, Joseph D;
    • Silverman, Ian M;
    • Wainszelbaum, Marisa;
    • Xu, Yi;
    • Ulanet, Danielle;
    • Koehler, Maria;
    • Yap, Timothy A
    Publication type:
    Article
    6

    Modeling Metastatic Colonization in a Decellularized Organ Scaffold‐Based Perfusion Bioreactor (Adv. Healthcare Mater. 1/2022).

    Published in:
    Advanced Healthcare Materials, 2022, v. 11, n. 1, p. 1, doi. 10.1002/adhm.202270001
    By:
    • Rafaeva, Maria;
    • Horton, Edward R.;
    • Jensen, Adina R.D.;
    • Madsen, Chris D.;
    • Reuten, Raphael;
    • Willacy, Oliver;
    • Brøchner, Christian B.;
    • Jensen, Thomas H.;
    • Zornhagen, Kamilla Westarp;
    • Crespo, Marina;
    • Grønseth, Dina S.;
    • Nielsen, Sebastian R.;
    • Idorn, Manja;
    • Straten, Per thor;
    • Rohrberg, Kristoffer;
    • Spanggaard, Iben;
    • Højgaard, Martin;
    • Lassen, Ulrik;
    • Erler, Janine T.;
    • Mayorca‐Guiliani, Alejandro E.
    Publication type:
    Article
    7

    Modeling Metastatic Colonization in a Decellularized Organ Scaffold‐Based Perfusion Bioreactor.

    Published in:
    Advanced Healthcare Materials, 2022, v. 11, n. 1, p. 1, doi. 10.1002/adhm.202100684
    By:
    • Rafaeva, Maria;
    • Horton, Edward R.;
    • Jensen, Adina R.D.;
    • Madsen, Chris D.;
    • Reuten, Raphael;
    • Willacy, Oliver;
    • Brøchner, Christian B.;
    • Jensen, Thomas H.;
    • Zornhagen, Kamilla Westarp;
    • Crespo, Marina;
    • Grønseth, Dina S.;
    • Nielsen, Sebastian R.;
    • Idorn, Manja;
    • Straten, Per thor;
    • Rohrberg, Kristoffer;
    • Spanggaard, Iben;
    • Højgaard, Martin;
    • Lassen, Ulrik;
    • Erler, Janine T.;
    • Mayorca‐Guiliani, Alejandro E.
    Publication type:
    Article
    8

    ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling – a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial.

    Published in:
    BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10632-9
    By:
    • Kringelbach, Tina;
    • Højgaard, Martin;
    • Rohrberg, Kristoffer;
    • Spanggaard, Iben;
    • Laursen, Britt Elmedal;
    • Ladekarl, Morten;
    • Haslund, Charlotte Aaquist;
    • Harsløf, Laurine;
    • Belcaid, Laila;
    • Gehl, Julie;
    • Søndergaard, Lise;
    • Eefsen, Rikke Løvendahl;
    • Hansen, Karin Holmskov;
    • Kodahl, Annette Raskov;
    • Jensen, Lars Henrik;
    • Holt, Marianne Ingerslev;
    • Oellegaard, Trine Heide;
    • Yde, Christina Westmose;
    • Ahlborn, Lise Barlebo;
    • Lassen, Ulrik
    Publication type:
    Article
    9

    Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 6, p. 997, doi. 10.1093/neuonc/noab274
    By:
    • Doz, François;
    • Tilburg, Cornelis M van;
    • Geoerger, Birgit;
    • Højgaard, Martin;
    • Øra, Ingrid;
    • Boni, Valentina;
    • Capra, Michael;
    • Chisholm, Julia;
    • Chung, Hyun Cheol;
    • DuBois, Steven G;
    • Gallego-Melcon, Soledad;
    • Gerber, Nicolas U;
    • Goto, Hiroaki;
    • Grilley-Olson, Juneko E;
    • Hansford, Jordan R;
    • Hong, David S;
    • Italiano, Antoine;
    • Kang, Hyoung Jin;
    • Nysom, Karsten;
    • Thorwarth, Anne
    Publication type:
    Article